Which moves will Amazon, CVS & Walgreens make this year?

The latest stories trending on MedCity News.

Editor's Pick

Top Story Which Moves Should Providers Watch From Amazon, CVS & Walgreens This Year? Analysts predict that disruptors could own as much as 30% of the $260 billion primary care market by 2030. A recent report from the American Hospital Association outlines major moves the healthcare industry should be watching this year from disruptors like Amazon, CVS and Walgreens — from billion-dollar acquisitions of primary care companies to expanding clinic locations to efforts in the home care space. Startups Get in Front of These Investors - Here's How: Sofia Guerra, Investor, Bessemer Venture Partners and Harry Glorikian, General Partner, Scientia Ventures   There is no fee to apply. Only companies funded from 2018-2022, and that have raised a seed funding round will be considered. Startups can apply to only one track. There are five tracks and each track will feature six finalists. Application Deadline: February 28, 2023. Selections will be announced on March 22, 2023.   Apply Now

Featured News

Elation Health Buys Medical Billing Company to Create All-in-One Tech Platform for Primary Care Providers Elation Health announced its acquisition of medical billing company Lightning MD — a deal the company made to help it become an all-in-one technology platform for primary care providers. Lighting MD stood out from other medical billing startups because of its ease of use, Elation CEO Kyna Fong said. How to Leverage Diagnostic Development to Guard Against RSV, Flu and Covid-19 A webinar sponsored by BD scheduled for March 7 will explore how diagnostics companies are working with healthcare organizations to guard against the perfect storm of Covid-19, RSV and influenza. Register today! Blood Biotech Grifols Cuts Deep in the U.S. to Find €400M in Savings Grifols said the layoffs sparked by its restructuring represent just 8% of its workforce. But the cuts will happen mainly in the Barcelona-based company's U.S. plasma operations, source of most of the plasma that is the basis for its biologic medicines. BCBS Tennessee Unveils Health Disparities in First Health Equity Report BlueCross BlueShield of Tennessee's health equity report analyzed disparities in behavioral health, cancer, child and adolescent care, chronic condition management, Covid-19 and maternal health. HHS Aims To Reduce Prescription Drug Costs Through 3 New Models The U.S. Department of Health & Human Services announced three models Tuesday that will be tested by the CMS Innovation Center and aim to lower prescription drug costs. The models, which include access to $2 generic drugs, build on the Inflation Reduction Act of 2022. Heartpoint Global Hopes To Disrupt Congenital Pulmonary Hypertension Treatment With Minimally Invasive Device A new treatment under development by HeartPoint Global seeks to provide a minimally invasive and cheaper alternative to current treatments for pulmonary arterial hypertension. MD Anderson's Tech Puts Replay on Fast Path to Clinic With TCR NK Cell Therapies Syena, the latest company formed by startup creator Replay, is developing cancer treatments based on a type of immune cell called a natural killer cell. This NK cell therapy technology, licensed from The University of Texas MD Anderson Cancer Center, could overcome many of the limitations facing first-generation cell therapy. Healthcare and Gen X: 4 Things Marketers Need to Get Right Gen X is at the height of its spending potential. Its U.S. population of 65 million has saved a collective $13 trillion and owns 29% of the nation's household wealth (versus just 6.4% owned by millennials).

Resources

Startup 101: Providing Best Practices for Healthcare Entrepreneurs Get the tools necessary to make the right decisions, know what strategies to avoid, and learn how to approach potential healthcare customers.   Download Now

MedCity News • 611 Broadway • New York, NY unsubscribe